Abstract: A pool liner retaining system having a pool wall structure that includes a plurality of interlocking panels and methods of constructing a pool wall structure using such interlocking panels are disclosed.

Abstract: A pool liner retaining system having a pool wall structure that includes a plurality of interlocking panels and methods of constructing a pool wall structure using such interlocking panels are disclosed.

Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (FVO) MSP-142. The method of the present invention produces a highly purified protein that retains folding and disulfide bridging of the native molecule. The recombinant MSP-142 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

Abstract: A vaccine composition comprising a Th1-inducing adjuvant in combination with a protecting Liver Stage Antigen or immunological fragment thereof of a human malaria parasite, especially Plasmodium falciparum, with the proviso that when the immunological fragment is an immunological fragment of LSA-3 the Th1-inducing adjuvant is not Montanide. In one preferred aspect the Th1-inducing adjuvant comprises QS21, De-O-acylated monophosphoryl lipid A (3D-MPL) and an oil in water emulsion wherein the oil in water emulsion has the following composition: a metabolisible oil, such a squalene, alpha tocopherol and tween 80. In a further preferred aspect the protecting Liver Stage Antigen is Liver Stage Antigen 3 (LSA-3) or an immunological fragment thereof. A multivalent vaccine composition is also provided comprising the vaccine composition of the invention and in addition at least one other protecting antigen or an immunological fragment thereof, of a malaria parasite.

Abstract: A vaccine composition comprising a Th1-inducing adjuvant in combination with a protecting Liver Stage Antigen or immunological fragment thereof of a human malaria parasite, especially Plasmodium falciparum, with the proviso that when the immunological fragment is an immunological fragment of LSA-3 the Th1-inducing adjuvant is not Montanide. In one preferred aspect the Th1-inducing adjuvant comprises QS21, De-O-acylated monophosphoryl lipid A (3D-MPL) and an oil in water emulsion wherein the oil in water emulsion has the following composition: a metabolisible oil, such a squalene, alpha tocopherol and tween 80. In a further preferred aspect the protecting Liver Stage Antigen is Liver Stage Antigen 3 (LSA-3) or an immunological fragment thereof. A multivalent vaccine composition is also provided comprising the vaccine composition of the invention and in addition at least one other protecting antigen or an immunological fragment thereof, of a malaria parasite.

Abstract: A microtiter reaction system (15), comprising, a support rack (16) having an array of reaction wells (18) disposed therein, each reaction well (18) having an open top end (30) and a closed bottom end (32); a plurality of generally funnel shaped reactor caps (20) with each of reactor cap (20) being received into open top end (30) of each reaction well (18); a porous gas-permeable layer (22) positioned over support rack (16), gas-permeable layer(22) having an array of holes (23) therein with each hole (23) being positioned over open top end (30) of each of the plurality of reaction wells (18); gasket (24) positioned over porous gas-permeable layer (22); and a top cover (26) positioned over gasket (22).